Progress in Pediatric Cardiology
Volume 24, Issue 1 , Pages 47-49 , November 2007

Giant cell myocarditis in children

  • Leslie T. Cooper Jr.

      Affiliations

    • Corresponding Author InformationDivision of Cardiovascular Diseases, Mayo Clinic 200 First Street SW, Rochester, MN 55905, United States. Tel.: +1 507 284 3680; fax: +1 507 266 0228.

References 

  1. Goldberg GM. Myocarditis of the giant-cell type in an infant. Am J Clin Pathol. 1955;25:510–513
  2. Das B, et al. Cardiac transplantation for pediatric giant cell myocarditis. J Heart Lung Transplant. 2006;25(4):474–478
  3. Cooper LT, Berry GJ, Shabetai R. Giant cell myocarditis: natural history and treatment. N Engl J Med. 1997;336:1860–1866
  4. Daubeney P, et al. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circ. 2006;114(24):2671–2678
  5. Towbin J, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296(15):1867–1876
  6. Kilgallen CM, et al. A case of giant cell myocarditis and malignant thymoma: a postmortem diagnosis by needle biopsy. Clin Cardiol. 1998;21(1):48–51
  7. Cooper L, et al. A prospective treatment trial of immunosuppression for giant cell myocarditis. Circ. 2006;114(18):626;(Suppl IV)
  8. Brikalas E, et al. Role of ventricular assist device support as a bridge to transplantation in giant cell myocarditis (abstract). J Heart Lung Transplant. 1999;18(1):31
  9. Singh TP, et al. Total lymphoid irradiation: new therapeutic option for refractory giant cell myocarditis. J Heart Lung Transplant. 2004;23(4):492–495

PII: S1058-9813(07)00076-8

doi: 10.1016/j.ppedcard.2007.08.002

Progress in Pediatric Cardiology
Volume 24, Issue 1 , Pages 47-49 , November 2007

Article Tools